Sigma Healthcare Limited (S5YA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sigma Healthcare Limited (S5YA) has a cash flow conversion efficiency ratio of 0.047x as of January 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€22.39 Million ≈ $26.18 Million USD) by net assets (€477.77 Million ≈ $558.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sigma Healthcare Limited - Cash Flow Conversion Efficiency Trend (2017–2023)
This chart illustrates how Sigma Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sigma Healthcare Limited (S5YA) total liabilities for a breakdown of total debt and financial obligations.
Sigma Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sigma Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Korea Electric Power Corp
KO:015760
|
0.127x |
|
Repsol S.A.
MC:REP
|
0.048x |
|
Joint Stock Commercial Bank for Foreign Trade of Vietnam
VN:VCB
|
0.040x |
|
Centrais Electricas Brasileiras SA
NYSE:EBR
|
0.039x |
|
Dupont De Nemours Inc
NYSE:DD
|
0.005x |
|
Vale S.A
BA:VALE
|
0.061x |
|
Dollar Tree Inc
NASDAQ:DLTR
|
0.056x |
|
Leidos Holdings Inc
NYSE:LDOS
|
0.100x |
Annual Cash Flow Conversion Efficiency for Sigma Healthcare Limited (2017–2023)
The table below shows the annual cash flow conversion efficiency of Sigma Healthcare Limited from 2017 to 2023. For the full company profile with market capitalisation and key ratios, see Sigma Healthcare Limited (S5YA) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-01-31 | €477.77 Million ≈ $558.56 Million |
€142.74 Million ≈ $166.88 Million |
0.299x | +415.53% |
| 2022-01-31 | €488.78 Million ≈ $571.43 Million |
€-46.28 Million ≈ $-54.11 Million |
-0.095x | -285.89% |
| 2021-01-31 | €534.90 Million ≈ $625.36 Million |
€-13.12 Million ≈ $-15.34 Million |
-0.025x | -105.77% |
| 2020-01-31 | €476.74 Million ≈ $557.36 Million |
€202.75 Million ≈ $237.04 Million |
0.425x | +2482.27% |
| 2019-01-31 | €514.28 Million ≈ $601.25 Million |
€8.47 Million ≈ $9.90 Million |
0.016x | -88.08% |
| 2018-01-31 | €515.26 Million ≈ $602.39 Million |
€71.18 Million ≈ $83.22 Million |
0.138x | -48.96% |
| 2017-01-31 | €538.59 Million ≈ $629.66 Million |
€145.77 Million ≈ $170.42 Million |
0.271x | -- |
About Sigma Healthcare Limited
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded n… Read more